CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS: CNBX · Delayed Price · USD
0.0130
+0.0010 (8.56%)
Apr 25, 2024, 3:55 PM EDT - Market closed
CNBX Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.41 | 0.03 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.11 | 0 | 0 | Upgrade
|
| Revenue Growth (YoY) | 1269.13% | - | - | -27.29% | 2.52% | 68.91% | -94.95% | - | - | - | Upgrade
|
| Cost of Revenue | 0.16 | 0.2 | 0.22 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | 0.25 | -0.17 | -0.22 | 0.01 | 0.01 | 0.01 | -0 | 0.11 | 0 | 0 | Upgrade
|
| Selling, General & Admin | 0.91 | 1.77 | 0.83 | 1.37 | 1.77 | 2.81 | 1.61 | 0.22 | 0.39 | 0.21 | Upgrade
|
| Research & Development | 0.43 | 1.18 | 1.77 | 1.68 | 1.54 | 1 | 0.25 | 0.18 | 0.14 | 0 | Upgrade
|
| Other Operating Expenses | -0.05 | -0.72 | -0.71 | -4.36 | 0.02 | -0 | 0 | -0 | 0.01 | 0 | Upgrade
|
| Operating Expenses | 1.34 | 2.95 | 2.6 | 3.05 | 3.31 | 3.82 | 1.86 | 0.39 | 0.54 | 0.22 | Upgrade
|
| Operating Income | -0.93 | -2.95 | -2.6 | -3.04 | -3.3 | -3.81 | -1.85 | -0.28 | -0.54 | -0.22 | Upgrade
|
| Interest Income | 0 | 0 | 0 | 0.01 | 4.36 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0 | 0 | 0 | 0.01 | 0.02 | 0 | 0 | 0.03 | 0 | 0 | Upgrade
|
| Other Expense / Income | 2.83 | 0.77 | 0.59 | 4.42 | -0.13 | -0.07 | 0.07 | -0.03 | -0 | 0 | Upgrade
|
| Pretax Income | -3.71 | -3.72 | -3.19 | -7.47 | 1.13 | -3.78 | -1.93 | -0.31 | -0.54 | -0.22 | Upgrade
|
| Income Tax | -0.05 | 0.05 | -0.7 | -4.35 | 0.04 | 0.03 | 0 | 0.03 | 0 | 0.05 | Upgrade
|
| Net Income | -3.71 | -3.77 | -2.49 | -3.11 | 1.13 | -3.78 | -1.93 | -0.31 | -0.54 | -0.27 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change | 621.77% | 5.92% | 2.95% | 1.59% | 10.03% | 9.06% | 6.90% | 2.53% | 0.46% | 7269.29% | Upgrade
|
| EPS (Basic) | -0.42 | -3.08 | -2.16 | -2.78 | 1.03 | -3.76 | -2.10 | -0.36 | -0.65 | -0.32 | Upgrade
|
| EPS (Diluted) | -0.42 | -3.08 | -2.16 | -2.78 | 1.03 | -3.76 | -2.10 | -0.36 | -0.65 | -0.32 | Upgrade
|
| Free Cash Flow | -0.11 | -1.68 | -2.49 | -2.85 | -3.31 | -2.92 | -0.99 | -0.12 | -0.18 | -0.23 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -1.37 | -2.16 | -2.54 | -3.00 | -2.91 | -1.08 | -0.14 | -0.22 | -0.27 | Upgrade
|
| Gross Margin | 60.49% | -562.68% | - | 100.00% | 100.00% | 99.99% | -23.49% | 100.00% | - | - | Upgrade
|
| Operating Margin | -227.07% | -9860.37% | - | -42524.12% | -33563.01% | -39670.12% | -32616.08% | -249.49% | - | - | Upgrade
|
| Profit Margin | -904.57% | -12581.02% | - | -43490.25% | 11510.41% | -39335.66% | -34022.54% | -273.05% | - | - | Upgrade
|
| Free Cash Flow Margin | -27.43% | -5610.68% | - | -39830.98% | -33634.70% | -30383.15% | -17405.74% | -106.76% | - | - | Upgrade
|
| Effective Tax Rate | - | - | - | - | 3.35% | - | - | - | - | - | Upgrade
|
| EBITDA | -0.82 | -3.48 | -3.15 | -7.25 | -3.1 | -3.75 | -1.85 | -0.28 | -0.54 | -0.22 | Upgrade
|
| EBITDA Margin | -200.93% | -11608.52% | - | -101317.54% | -31444.24% | -39083.42% | -32492.59% | -248.09% | - | - | Upgrade
|
| Depreciation & Amortization | 0.16 | 0.2 | 0.22 | 0.22 | 0.19 | 0.09 | 0.01 | 0 | 0 | 0 | Upgrade
|
| EBIT | -0.99 | -3.68 | -3.37 | -7.47 | -3.28 | -3.84 | -1.85 | -0.28 | -0.54 | -0.22 | Upgrade
|
| EBIT Margin | -240.44% | -12271.20% | - | -104323.75% | -33363.66% | -40004.57% | -32616.08% | -249.49% | - | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.